View the latest ETF prices and news for better ETF investing. "The top five holdings in XBI, as of Dec. Rated on Jun 30, 2023 Published on Jun 30. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 79 in February 2021 and has fallen over (50%) to $76. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. 11. 66 +2. 94 per share, with $174. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 52%. Krane Carbon Cfc (138001) 18. XBI: SPDR S&P Biotech ETF - Fund Holdings. Performance. View Holdings As of 09/30/2023. 58 đž. A few losers won't cause XBI to crash. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. While this ETF allocates. âą. . TipRanks | Stock Market Research, News and Analyst Forecasts. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. The index and exchange-traded fund ETF are rebalanced four times a year. 80% of total assets under management. 47 and a beta of 0. m. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Company Change % Net. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 10 as of November 2, 2022. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. IBB's and XBI's Top Holdings are About to Break Out. 12 and $91. Mettler-Toledo International Inc. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. Follow. Looking at the chart above, XBI's low point in its 52 week range is $68. Holdings AS OF 04/30/2023. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. 15 billion. 7657M. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. iShares Biotechnology ETF ETF holdings by MarketWatch. The vast majority of XBI holdings have less. 86% so far this year and is down about -32. Top 10 Holdings. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. Its price to cash flow multiples is about 13. 22%: Revolution. Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing. 2. 12 and $91. 2. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. 35%. 2. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. 50. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI holdings. All 142 XBI Holdings. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Message board - Online Community of active, educated investors researching and discussing Alaunos Therapeutics, Inc. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 6% of the fund. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. $0. Fund Analysis. BTEK11. 08 per unit, that means that analysts see 59. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. Performance and Risk. 88%. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Staples:. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 98 and standard deviation of 40. Research performance, expense ratio, holdings, and volatility to see if it's the. 97. Fund Size Comparison. 94 per share, with $107. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 250-590-1718. Looking at the chart above, XBI's low point in its 52 week range is $62. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 12% in the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDRâ S&Pâ Biotech ETF (Symbol: XBI) where we have detected an. XBI is suitable for investors seeking to. IMVT. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 97% in the last one year (as of 11/07/2022). SPDR® S&P Biotech ETF. The portfolio of Cathie Wood updated daily. XBI Holdings5 Beaten-Down ETFs to Buy Now. 60 as the 52 week high point â that compares with a last trade of $77. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. 06 as the 52 week high point â that compares with a last trade of $112. 2% Top Ten Holdings. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 1. 08%. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. 09% of its total assets under management. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. View complete XLP exchange traded fund holdings for better informed ETF trading. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. 70% so far this year and is down about -16. The ETF has lost about -30. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 4% of the stocks in our database. View complete XBI exchange traded fund holdings for better informed ETF trading. IBB outperformed the S&P 500 last year and did much better than XBI. Fund size is a good indication of how many other investors trust this fund. 0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. In addition to holding 155 positions, its top 10. 93% of its total assets under management. . Seagen Inc Ordinary Shares. One of the ideas making the rounds on Wall Street right now (Iâve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. 12% over the last 12 months (as of 07/18/2023). XBI has a lower 5-year return than XLV (-5. 5%, and a 2. XBI's top 10 holdings account for about 14. As I understand it, this attribute was added to the methodology to protect against having too. 32% of the total portfolio assets. View complete YINN exchange traded fund holdings for better informed ETF trading. IBBâs holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. $0. 1% and 1. LABU has a lower 5-year return than XBI (-46. 1. Summary. 51 on Tuesday. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 0. Major Holdings. large-cap stocks. 78% in the last one year. The top 10 holdings account for about 10. Taking a look at the XBI, it peaked at $174. Before you invest in the SPDR ® S&P Biotech ETF (the âFundâ), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. XBI - SPDR® S&P Biotech ETF - Review the XBI stock price, growth, performance,. ARKK ARKG. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 64 per share, with $174. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . SPDRÂź S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. The beaten-down prices offer a solid buying opportunity for investors. S. 1% which highlights the scope of the fund and diversification away from company-specific risks. 56, which is an increase of 43. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. The current portfolio value is calculated to be $6. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. Chart. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. XBI has traded between $62. BlackRock Files for Spot Ethereum ETF. 01% vs 0. 07. Brazil. $7. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. 78% so far this year and in the past one year (as of 11/20/2023), respectively. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 67. The top 10 holdings account for about 11. February 15, 2023 â 10:47 am EST. 12% in the. Shares of Amgen , IBB's top holding with a weight of 8. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. While I love Cathie Wood, I just don't see how she can keep this up. 45% and is down about -9. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc. The ETF has lost about -22. The split for XBI took place on September 11, 2015. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. by Morningstar Manager Research. XBI focuses on health care investments and follows the S&P Biotech Index. Its holdings reflect the movement of like 750b worth of companies. No company usually makes up more than two percent of. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Free ratings, analyses, holdings, benchmarks, quotes, and news. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The fund has a beta of 0. $0. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 48%: Number of Holdings 78: Price/Book Ratio ï»żPrice/Book Ratio. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. 73% so far this year and is down about -39. ARKG vs XBI Fund Comparison . Comparing the most. LABD. 58%). com. Holdings Details. NEW: Experience our best charts yet. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. Jun 23, 2022 10:49AM EDT. S. 2014. XBI holdings. All 142 XBI Holdings. Thu, Nov 9, 1:16 PM ET, Market News Video. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Top 10 Holdings (14. Holdings. 15 billion assets under management. 2015. 64 per share, with $174. Follow. 78% of XBI's total assets under management. 00 (0. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. The stock holdings of the XBI tends to be re. 58% and is down about -14. Front end load. 15 during this last 52-week period. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. 2 %. WisdomTree Cloud Computing Fund ETF holdings by MarketWatch. Rather than analyzing the holdings of all ETFs and deciding which allocation is best it is easier to pick two that encompass large caps FBIOX or IBB and small/mid caps with equal weighting like the XBI. N/A. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. Summary. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDRâ S&Pâ Biotech ETF (Symbol: XBI) where we have detected an. 35%. Again, top 10 holdings. 20. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 79 as the 52 week high point â that compares with a last trade of $159. According to data from U. The. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. But that definitely wasn't the case recently. com Ltd. 250-391-1110. $6. Net Expense Ratio. Wix. 06 and standard deviation of 38. Further, the fund owns $6. , including minimum market capitalization and. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. Implied XBI Analyst Target Price: $135. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. MRTX. Below is the comparison between ARKG and XBI. 81. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alphaâs top analysts: exclusive research and insights from bulls and bears. XBI ETF's holdings offer significant diversification. ARGX. Royal Gold Inc. XBI has an overall POWR Rating of D, equating to a Sell. The beaten-down prices offer a solid buying opportunity for investors. Growth of Hypothetical $10,000. RGLD. The sale of ETFs is subject to an activity assessment fee (from $0. 17% for the trailing three-year period, which makes XBI a high. S. 01 to $0. In XBI, the top five holdings together represent only 9. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Top 10 Holdings (14. Dividend Yield. Vertex Pharmaceuticals (VRTX 0. NAV as of Nov 09, 2023. 1. Holdings. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. 03 per $1,000 of principal). Performance and Risk. 003 on 06/20/23 ; Management Fee 0. ARGX. There is no guarantee the fund will achieve its stated investment objective. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 19%. Advertisement. The weighted harmonic average of closing market price divided by. 47 and a beta of 0. Top Holdings . 98 and standard deviation of 37. 10(-0. Viehbacher reported, âIn the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimerâs disease and ALS, while also delivering on our. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. In contrast, most. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). 1%). Looking at the chart above, XBI's low point in its 52 week range is $100. SBIO holds 79 companies vs. Currently, the. NAV as of Nov 16, 2023. Holdings. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. Carnage in small and micro-cap biotech stocks took XBI from $111. 191), IBB is significantly more concentrated in its top ten holdings than XBI. Holdings. Shares of XBI stock opened at $73. SPDR S&P Biotech ETF ETF holdings by MarketWatch. 66 +2. 66%. 06 and standard deviation of 38. Name Symbol % Assets. 97. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. With XBI trading at a recent price near $131. 35%. 35%). 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. 1% over the past year to close the last trading session at $81. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Below is the comparison between XBI and XLV. Performance and Risk. XBI holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 84%: Other: 0. 94 as the 52 week high point â that compares with a last trade of $116. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 97. Implied XBI Analyst Target Price: $135. XBI is suitable for investors seeking to. FBT has a higher 5-year return than XBI (-0. 45% vs 0. Top 10 Holdings. Seeks to track a modified. View the latest SPDR S&P Biotech ETF (XBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. Looking at the chart above, XBI's low point in its 52 week range is $72. In addition to holding 155 positions, its top 10 holdings make up just 14. 13%) Gold 1,980. 35%). 7% of assets. ETFs are subject to market fluctuation and the risks of their underlying investments. IBBâs holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. As of Oct 31 2023. 5. | Medalist Rating as of Sep 30, 2023 | See State Street Investment Hub. 73. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. Themes & Subsectors ETFs. 35%). 7,569,600. by Sweta Killa Published on September 18,2023. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Both ARKG and XBI are ETFs. 2 %. Immunovant Inc. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 19%. 70% so far this year and is down about -16. The firm has a market cap of $5. $0. Health Care Fund Highlights: 137 Total Holdings $5. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. Top Holdings . Looking at the chart above, XBI's low point in its 52 week range is $62. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. 50. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a âcovered callâ or âbuy-writeâ strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and âwritesâ or âsellsâ corresponding call options on the same index. Reply Like (7) q. 54%. Looking at the chart above, XBI's low point in its 52 week range is $62. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. VEEV. News & World Report, XBI. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Lucy Brewster | Nov 10, 2023.